Cognitive impairment in cerebral small vessel disease induced by hypertension

Weipeng Wei1,2, Denglei Ma1,2, Lin Li1,2

  • 1Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China.

PubMed

Insights

Hypertension significantly drives cerebral small vessel disease, leading to cognitive impairment. This review clarifies the link between high blood pressure and brain changes, discussing potential treatments.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Gerontology

Background:

  • Hypertension is a major risk factor for cognitive impairment linked to cerebral small vessel disease (CSVD).
  • The exact causal link between hypertension and CSVD remains incompletely understood.
  • CSVD is the most common cerebrovascular disease, often leading to stroke and dementia.

Purpose of the Study:

  • To review the pathogenesis of hypertension-induced CSVD.
  • To elucidate the impact of hypertension on brain structure, function, and cognitive decline.
  • To discuss therapeutic strategies for CSVD and associated cognitive impairment.

Main Methods:

  • Literature review focusing on hypertension, CSVD, and cognitive impairment.
  • Analysis of mechanisms linking hypertension to cerebrovascular changes.
  • Synthesis of current understanding of pathogenesis and treatment.

Main Results:

  • Hypertension is identified as the primary driver of CSVD.
  • Hypertension-induced vascular changes lead to lacunar infarction, leukoaraiosis, white matter lesions, and intracerebral hemorrhage.
  • The brain is confirmed as a target organ of hypertension, with significant cognitive decline observed.

Conclusions:

  • Hypertension critically contributes to CSVD pathogenesis and subsequent cognitive decline.
  • Understanding these mechanisms is crucial for developing effective treatments.
  • Further research into therapeutic interventions for hypertension-related brain damage is warranted.